Is there a difference in outcomes with Hybresis versus traditional iontophoresis?
Hybresis is a device that was actually developed by a company called iOMED. IOMED was bought out by Empi and Empi branded this device and called it Hybresis. Now here is what this device does. You apply your medication to an electrode. That electrode has a built in battery. You put the medication on the electrode and then you put that electrode on the patient. You then apply a little thing that looks like a guitar pick onto the electrode. That applies three minutes of high level stim. Then that "guitar pick" can be taken off after the three minutes of stim. So what happens during those three minutes of stim? What happens is called impedance enhancement. It hydrates the skin and induces electroporation. So by inducing electroporation, that seems to make the medication go in there a little bit better. Now is there evidence on this? No, the Hybresis unit is still pretty early in the evidence pipeline. There are studies ongoing - actually done by a few colleges of mine - and they are showing some promise. It makes sense that these Hybresis devices - you do the three minutes of higher level stimulation and then you take the Hybresis device off and it delivers three hours of low level stimulation. And that makes sense that that would deliver more medication, but then again the research studies are not out there as of yet, so keep your eyes and ears open.
Andrew Starsky, PT, PhD
Andrew Starsky earned a Bachelor of Science in Electrical Engineering Degree from Marquette University in 1992. After practicing in the engineering field for 3 years, he returned to Marquette and received a Masters of Physical Therapy degree in 1998. While working full time, he starting to pursue a terminal degree in Biomedical Engineering and received his Ph.D. in 2007. He has been part of the adjunct faculty since 1999 and became a full time Clinical Assistant Professor in 2005. Andrew teaches the didactic portion of the DPT program in the 5th and 6th years. He lives in Mequon with his wife and 4 kids and is an active participant in ultramarathons, Nordic ski races, and adventure races.
This course is intended for rehabilitation professionals who have recreational or competitive middle or long distance runners as part of their practice population. It will provide them with therapeutic exercise interventions to treat common problems among these runners.
In the past 20 years Neuroscience has made major advances in the understanding of the brain mechanisms involved in the acquisition of skilled performance. It is now known that the potential for central nervous system neuroplasticity exists over an individual’s lifetime and underlies behavioral gains as healthy individuals learn new motor skills. While manual therapy is important for relieving symptoms of musculoskeletal pathology, physical therapists need to come from the perspective that motor learning-induced neuroplasticity will more permanently prevent faulty movement strategies in the performance of daily as well as athletic tasks. Importantly, substantial evidence exists that the brain can be modified in older individuals through intensive training thereby reversing age-related alterations in motor and cognitive function. This webinar will explore research in neuroplasticity and provide evidence neuroplastic changes underlying the acquisition of skilled performance.
The objective of this presentation is to help clinicians learn strategies for treating injuries and dysfunction in recreational and competitive runners through manipulating the interface with the ground. We will discuss the forces applied to the lower extremity during running, how those forces are different in running with conventional running shoes and running barefoot or in “minimalist shoes”, and when and how we might prescribe running barefoot or “minimalist” for the sake of rehabilitation or enhanced training. We will explore easy shoe modifications that can enhance healing of running related injuries. Although we will discuss functional foot orthotics, this course includes no instruction in the fabrication of such orthotics.
Editor's Note: Regarding Pennsylvania credits, this course is approved by the PA State Board of Physical Therapy for 2 hours of General CE Credit, from 6/03/14-12/31/14.
This course will review current evidence regarding diagnostic imaging in shoulder. Content will include indications for various imaging studies, the accuracy of selected special tests and imaging modalities for various shoulder pathology, imaging for selected shoulder pathology with emphasis on plain radiographs, and case presentations highlighting the impact of imaging on physical therapy treatment plans. Upon conclusion of this course, participants will have a better understanding of the role of imaging in the diagnosis and treatment of shoulder injuries.
Editor's Note: Regarding Pennsylvania credits, this course is approved by the PA State Board of Physical Therapy for 2 hours of Direct Access CE, from 5/07/14-12/31/14.
'Good overview of indications for imaging and how to use the results'Read Reviews
Please note: This course is also offered in a series of recordings titled " Non-arthritic, Intra-articular Hip Pathology", course 1715.
This presentation will describe the recent advances and literature in epidemiology, differential diagnosis, and anatomy and pathophysiology associated with non-arthritic, intra-articular hip pathology. Additionally, the latest available evidence regarding subjective reports, physical examination, and imaging will be presented.
'The information provided was very well done and pertinent to hip patients'Read Reviews